News 6/29/23
This week, Equitas Health Interim CEO & Chief Advancement Officer Robert Copeland informed the Board of Trustees that he has elected to step down.
The Board thanks Robert for his many years of service and wishes him well as he moves on to other endeavors. The Board has engaged a national search firm to identify a permanent successor. In the interim, the Board is confident in the leadership team’s ability to maintain continuity for our patients, communities and teams throughout this transition, with an unrelenting focus on our mission to provide quality, affirming care for all.
The Board understands that patients and community partners may have questions about next steps in Equitas Health leadership, and it welcomes this feedback. To share your questions and concerns, please email board@equitashealth.com. All correspondence goes directly to Board members, who will make every effort to respond promptly.
Blog 3/25/24
Blog 2/26/24
News 6/29/23
Blog 4/18/23
In late January 2023, the Food and Drug Administration (FDA) proposed changes to their guidance on who can give blood. Historically, their rules have discriminated against members of the LGBTQ+ community. As promised, Equitas Health gave feedback to the FDA in a public comment.
Blog 2/28/23
